Seeking Alpha

Biogen (BIIB +1.8%) moves up after its Q4 easily beat EPS estimates earlier this morning....

Biogen (BIIB +1.8%) moves up after its Q4 easily beat EPS estimates earlier this morning. Earnings rose 25% Y/Y on faster than expected revenue growth, helped by a jump in sales of Tysabri and Avonex. The company guides lower for FY12 however, saying revenue growth is showing signs of slowing. It now anticipates low-to mid-single-digit revenue growth in 2012.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)